$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
Safety and effectiveness of erlotinib in the treatment of advanced lung cancer
2025-10-19 11:44:20
Check Details
How much will a box of erlotinib cost after it is included in medical insurance in 2021?
2025-10-19 11:44:20
Check Details
What is the price of ceritinib after medical insurance reimbursement in 2021?
2025-10-19 11:44:20
Check Details
Can ceritinib be used to treat brain metastases from lung cancer?
2025-10-19 11:44:20
Check Details
Ceritinib for the treatment of ALK-positive metastatic non-small cell lung cancer who are intolerant to crizotinib_Canghule
2025-10-19 11:44:20
Check Details
Ceritinib has significant effect in treating ALK-positive metastatic non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Safety and effectiveness of ceritinib in the treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
A new option for ALK-positive non-small cell lung cancer-lorlatinib
2025-10-19 11:44:20
Check Details
Effects and adverse reactions of ceritinib in the treatment of lung cancer
2025-10-19 11:44:20
Check Details
Survival of first-line treatment of lung cancer with lorlatinib
2025-10-19 11:44:20
Check Details
Survival period of ceritinib in the treatment of advanced lung cancer
2025-10-19 11:44:20
Check Details
Analysis of the efficacy of ceritinib in the treatment of ALK-positive lung cancer
2025-10-19 11:44:20
Check Details
1
2
...
9912
9913
9914
9915
9916
9917
9918
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
What diseases can Upatinib be used for? Which patients are suitable for use?
2
The efficacy of Eltrombopag
3
User Agreement
4
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
5
What is the most important information I should know about WELIREG?
6
How to take and store WELIREG
7
How to take TRUSELTIQ correctly
8
How to deal with LONSURF side effects (1)
9
How to deal with LONSURF side effects (2)
10
Cabozantinib (Cabometyx)-new indication approved
11
What should I pay attention to when using atezolizumab/Tecentriq?
12
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma